Eligibility for bevacizumab as an independent prognostic factor for patients with advanced non-squamous non-small cell lung cancer: a retrospective cohort study.
about
Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014.Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experienceDoublet chemotherapy with cisplatin and pemetrexed is associated with a favorable outcome in patients with advanced non-squamous non-small-cell lung cancer who are eligible for bevacizumab and maintenance therapy.A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016).Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy.Bevacizumab in the treatment of NSCLC: patient selection and perspectives.
P2860
Eligibility for bevacizumab as an independent prognostic factor for patients with advanced non-squamous non-small cell lung cancer: a retrospective cohort study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Eligibility for bevacizumab as ...... a retrospective cohort study.
@ast
Eligibility for bevacizumab as ...... a retrospective cohort study.
@en
Eligibility for bevacizumab as ...... a retrospective cohort study.
@nl
type
label
Eligibility for bevacizumab as ...... a retrospective cohort study.
@ast
Eligibility for bevacizumab as ...... a retrospective cohort study.
@en
Eligibility for bevacizumab as ...... a retrospective cohort study.
@nl
prefLabel
Eligibility for bevacizumab as ...... a retrospective cohort study.
@ast
Eligibility for bevacizumab as ...... a retrospective cohort study.
@en
Eligibility for bevacizumab as ...... a retrospective cohort study.
@nl
P2093
P2860
P1433
P1476
Eligibility for bevacizumab as ...... a retrospective cohort study.
@en
P2093
Akira Toriihara
Makiko Yomota
Masahiko Shibuya
Tatsuru Okamura
Yoshiro Nakahara
Yukio Hosomi
Yusuke Okuma
Yusuke Takagi
P2860
P304
P356
10.1371/JOURNAL.PONE.0059700
P407
P577
2013-03-26T00:00:00Z